Treatment

NIO752 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
This study is testing a new drug, NIO752, to see if it can reduce a protein called tau in the brains of people with early Alzheimer's disease. Too much tau builds up in Alzheimer's and causes damage. We want to see if this drug can help prevent that.
For: Alzheimer Disease · Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder) · Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)
United States · United Kingdom